share_log

德琪醫藥-B:2022 中期報告

ANTENGENE-B: 2022 INTERIM REPORT

Sep 23, 2022 04:31
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more